Pierluigi Vergara MD FRCS,1 Dominic G O'Donovan MBChB FRCPath2
1Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge University Hospital, Cambridge, UK, 2Department of Histopathology, Addenbrooke’s Hospital, Cambridge University Hospital, Cambridge, UK
Symptomatic spinal gout is relatively rare. Open laminectomy, with or without fusion, has been so far the standard treatment for symptomatic spinal gout. We describe here the first case of spinal tophaceus gout treated with minimally invasive surgery.
A 60-year-old patient, morbidly obese, with no previous history of gout, presented with neurogenic claudication due to severe lumbar canal stenosis at L3/4. Surgery was performed through a minimally invasive approach, using tubular retractors. During surgery, an extradural mass with a thin capsule and containing white “chalky” partially calcified material, slightly adherent to and compressing the theca, was removed.
There were no intra- or perioperative complications. Surgery successfully improved the functional status, with a significant increase in walking distance and no residual leg pain or neurogenic claudication. Histopathology confirmed the diagnosis of spinal tophaceous gout.
Although spinal gout is usually responsive to medical treatment, surgery is often the first line treatment, particularly in patients with neurological deficits. Would surgery be indicated, we believe that minimally invasive surgery can be effective in treating symptomatic spinal tophaceous gout. Level of Evidence: Class IV.
The incidence of gout is estimated to be 0.2-0.4% worldwide.1 Recent reports have shown an increase in the incidence; in fact almost 4% of the US population is affected by gout.2
Gout most commonly affects joints of hands, feet, knees, ankles and wrists. Although less frequently, gout could also involve the spine, with unknown frequency. Between 14% and 22% of patients with gout might have radiographic abnormalities of the spine,3,4 although these are often non-specific.
Gout could involve all the segments of the spine but it appears to be more common in the lumbar spine (44-54%).7,8 Deposits of tophaceous gout could be found in any part of the vertebra, including facet joint,9 vertebral body,10 pedicle,11 lamina,12 ligamentum flavum,13 and disc.14,15
Symptomatic spinal gout can present with features of back pain, spinal stenosis, myelopathy, radiculopathy and cauda equina syndrome.
One hundred and thirty three cases of spinal gout have been reported in the literature so far.8 Surgery, in the form of open laminectomy with or without fusion, appears to be still the first line treatment, with adjuvant medical treatment, particularly in patients presenting with neurological deficits.
Here we report the first case of symptomatic spinal tophaceous gout operated via a minimally invasive approach.
A 60 years old lady, morbidly obese (BMI 51), presented with four months history of debilitating lower back and right leg pain, associated with weakness and paraesthesiae. The patient was pretty much wheelchair bound, with walking distance limited to few steps only. No relevant medical history recorded. Neurological examination showed mild bilateral distal leg weakness (4/5), slightly more marked on the right side, reduced sensation to light touch on L4 and L5 distribution on the right and absent reflexes in both legs.
Due to claustrophobia and very high BMI, the patient was unable to undergo Magnetic Resonance of the spine. Dynamic lumbar Xrays showed diffuse degenerative changes with no evident instability at L3/4. A CT-myelogram showed severe lumbar stenosis at L3/4, with complete obliteration of the canal, and moderate stenosis at L2/3.
The patient was positioned prone, on an adapted Wilson frame for high BMI. We performed the operation using our standard minimally invasive technique for lumbar decompression via tubular retractors. Sequential dilators were inserted through a 2cm skin incision, up to 18mm of maximum diameter, and docked at the junction between the right lamina and the spinal process. A right L3 hemilaminotomy was performed with high-speed drill. The retractor was then angled more medially, toward the midline, and the operating table away from the surgeon, to allow access to the contralateral lateral recess. After drilling of the base of the spinal process and the ventral aspect of the left lamina, the ligamentum flavum was excised. An extradural mass with a thin capsule and containing white “chalky” partially calcified material, slightly adherent to and compressing the theca, was unexpectedly seen. After removal of the lesion, a full decompression of the theca, from edge to edge, was achieved.
Surgical time was 2 hours and estimated blood loss less than 50ml.
There were no intra- or perioperative complications. The patient reported immediate improvements of the symptomatology with no leg pain and less paraesthesiae. She was discharged home 24 hours postoperatively.
The histopatology was later to show compatible with Chronic Tophaceous Gout (Figure 2).
She was therefore referred to Rheumatology and started on Allopurinol.
Six months postoperatively, at her last follow-up, she reported excellent improvements with complete resolution of the preoperative leg pain and significant improvements of the paraesthesiae. Walking distance, still limited by high BMI related issues, increased to more than 100 meters.
Gout was first described within the spine by Kersley et al in 1950.16 It is characterized by the deposition of monosodium urate crystals and by acute and chronic inflammation in response to crystals deposited.
In a recent comprehensive review, back pain was the most common symptom (68.5%), while neurological impairment was present in 65.4% cases, with the two not being mutually exclusive.8
Blood tests usually show increased serum acid uric (>7 mg/dL) and raised inflammatory markers (ESR, CRP, WBC).
MRI findings are often non-specific, with only 21% of cases unequivocally interpreted as spinal gout, as shown by a recent review.8 In fact, gout tophi on MRi scan can appear as homogeneous areas of intermediate- to hypointensity signal on T1 and hyper- to hypointensity in T2. After gadolinium, the tophi show homogeneous or heterogeneous marginal enhancement, as result of well-vascularized chronic, inflammatory fibrous tissue, engendered by urate crystal deposition.7,17 CT, PET-CT and DECT scans could help with the diagnosis but they are not routinely performed in addition to MRi scans.
Due to the inconsistency between laboratory tests, radiological and clinical findings, the diagnosis is usually made during surgery. Intraoperatively, gouty tophi appear typically as chalky white nodules or masses, usually easily removed with suction, although the capsule of the mass can be sometimes adherent to the dura.
Under microscopy, the urate depositions are surrounded by multinucleated histiocytes, which are giant cells with foreign bodies associated with lymphoplasmocytic cells and fibroblasts.
Although a recent report suggests that conservative treatments can be as effective as surgical treatments, the first line treatment is usually surgery, reaching 61% of the cases report of spinal gout described in the literature.8 Surgery is usually most common in cases with neurology or where the differential diagnosis is suspicious of unfavourable pathologies such as infections or tumors.
Surgery usually consists of an open laminectomy or decompression, sometimes associated with fusion. In our case we have adopted a minimally invasive approach, similar to the one commonly used by the author for addressing degenerative lumbar canal stenosis. This has the advantage of a smaller incision, less soft tissue disruption, preservation of midline and contralateral structures. It has shown to be effective in addressing the pathology, as well as being extremely well tolerated by the patient (minimal blood loss, minimal postoperative pain, no intraoperative complication, etc). In our specific case, with very high BMI and high risk of perioperative morbidity, performing surgery via a minimally invasive approach with a very small incision (2cm) has also allowed to reduce significantly the risk of wound related issues, which are very common in this category of patients. However, while there was no complication like dural tear in this one particular case, the usual care should be taken when performing these types of procedures as the rates of dural tear and nerve injury are likely to be just as high as for minimally invasive lumbar decompression.
We therefore believe that minimally invasive decompression and excision of spinal tophi can be a valid and safe alternative to open approaches, would surgery be indicated. In fact, we believe that large laminectomies or more invasive spinal fusions can be avoided, especially considering the benign course of the pathology, which can be further treated with medications.
Due to the low incidence of symptomatic spinal gout (133 cases in the literature), we assume that large randomised studies would be extremely hard to be performed but, based on our experience, we advocate that minimally invasive approaches could be used when treating symptomatic spinal gout.
Symptomatic tophaceous spinal gout is a relatively rare condition. Although responsive to medical treatment, surgery in the form of laminectomy and excision of the tophi, is often the first line treatment, particularly in patients with neurological deficits or were the differential diagnosis include malignant or infective processes. Would surgery be indicated, we believe that minimally invasive surgery can be effective in treating symptomatic spinal tophaceous gout.
The patient consented to submission of this case report to the journal.
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Pierluigi Vergara, Box 166 – Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge University Hospitals, Hills Road, CB20QQ. email@example.com.